Xcel Pharmaceuticals
Xcel Pharmaceuticals currently focus on neurology, a segment of the CNS market where a limited number of high-prescribing physicians.
Launch date
Employees
Market cap
-
Enterprise valuation
€95—142m (Dealroom.co estimates Apr 2003.)
San Diego California (HQ)
Authorizing premium user...